Details

Novinarski potopis : v kraljevstvu Anapurne
ID Čujež, Marija (Author), ID Milosavljević, Marko (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://dk.fdv.uni-lj.si/diplomska/pdfs/cujez-marija.pdf This link opens in a new window

Language:Slovenian
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FDV - Faculty of Social Sciences
Place of publishing:Ljubljana
Publisher:[M. Čujež]
Year:2010
Number of pages:46 f.
PID:20.500.12556/RUL-18730 This link opens in a new window
UDC:070(043.2)
COBISS.SI-ID:29506909 This link opens in a new window
Publication date in RUL:11.07.2014
Views:14265
Downloads:188
Metadata:XML DC-XML DC-RDF
:
ČUJEŽ, Marija, 2010, Novinarski potopis : v kraljevstvu Anapurne [online]. Bachelor’s thesis. Ljubljana : M. Čujež. [Accessed 18 September 2025]. Retrieved from: http://dk.fdv.uni-lj.si/diplomska/pdfs/cujez-marija.pdf
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  2. Antibiotic prescription patterns in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors and their association with treatment outcomes
  3. Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
  4. Characteristics of treatment with proton pump inhibitors among lung cancer patients treated with immunotherapy at the University Clinic Golnik
  5. Prescribing patterns of metformin and paracetamol and their association with treatment outcomes with immune checkpoint inhibitors in patients with non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Vodnik za bolnike z nedrobnoceličnim pljučnim rakom v stadiju III
  2. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection
  3. Care of patients with non-small-cell lung cancer stage III
  4. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy

Back